Burkina Faso vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Mongolia
100.0%
in 2024
Burkina Faso rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Mongolia
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Mongolia ahead.
Burkina Faso ranks 1st and Mongolia ranks 1st of 144 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 1 and Mongolia in 2.
Head to head by decade
| Decade | Burkina Faso | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.5% | 83.2% | 40.8% | Mongolia |
| 2010s | 79.5% | 78.1% | 1.4% | Burkina Faso |
| 2020s | 93.2% | 100.0% | 6.8% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Mongolia?
- Burkina Faso, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Mongolia?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Mongolia?
- 18 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.